| 000 | 02772nam a22005295i 4500 | ||
|---|---|---|---|
| 001 | 978-3-319-00303-0 | ||
| 003 | DE-He213 | ||
| 005 | 20140220082837.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 130518s2013 gw | s |||| 0|eng d | ||
| 020 |
_a9783319003030 _9978-3-319-00303-0 |
||
| 024 | 7 |
_a10.1007/978-3-319-00303-0 _2doi |
|
| 050 | 4 | _aQR1-502 | |
| 072 | 7 |
_aPSG _2bicssc |
|
| 072 | 7 |
_aSCI045000 _2bisacsh |
|
| 082 | 0 | 4 |
_a579 _223 |
| 100 | 1 |
_aByers, B. Rowe. _eeditor. |
|
| 245 | 1 | 0 |
_aIron Acquisition by the Genus Mycobacterium _h[electronic resource] : _bHistory, Mechanisms, Role of Siderocalin, Anti-Tuberculosis Drug Development / _cedited by B. Rowe Byers. |
| 264 | 1 |
_aHeidelberg : _bSpringer International Publishing : _bImprint: Springer, _c2013. |
|
| 300 |
_aV, 92 p. 39 illus., 9 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aSpringerBriefs in Molecular Science, _x2191-5407 |
|
| 505 | 0 | _aA History of Iron Metabolism in the Mycobacteria -- Mycobacterial Iron Uptake Mechanisms -- Siderocalin Combats Mycobacterial Infections -- Design of Anti-TB Drugs Using the Iron Uptake Platform. | |
| 520 | _aIron Acquisition by the Genus Mycobacterium summarizes the early evidence for the necessity of iron in mycobacteria and the discovery of the mycobacterial siderophores mycobactin, carboxymycobactin, and exochelin. The structural characterization of the mycobacterial siderophores is described. The genes so far identified as essential for iron acquisition and maintenance of an infection by pathogenic mycobacteria are discussed. The potential role of siderocalin in iron gathering by M. tuberculosis is featured. Because new drugs for M. tuberculosis are needed, this brief also emphasizes the design of antibiotics that interfere with siderophore biosynthesis and the use of siderophore analogs and/or conjugates. | ||
| 650 | 0 | _aLife sciences. | |
| 650 | 0 | _aChemistry, inorganic. | |
| 650 | 0 | _aBioorganic chemistry. | |
| 650 | 0 | _aEmerging infectious diseases. | |
| 650 | 0 | _aRNA-ligand interactions. | |
| 650 | 0 | _aMicrobiology. | |
| 650 | 1 | 4 | _aLife Sciences. |
| 650 | 2 | 4 | _aMicrobiology. |
| 650 | 2 | 4 | _aProtein-Ligand Interactions. |
| 650 | 2 | 4 | _aInorganic Chemistry. |
| 650 | 2 | 4 | _aBioorganic Chemistry. |
| 650 | 2 | 4 | _aInfectious Diseases. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783319003023 |
| 830 | 0 |
_aSpringerBriefs in Molecular Science, _x2191-5407 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-319-00303-0 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c96390 _d96390 |
||